Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Alignment Healthcare (ALHC) Shares Outstanding (2020 - 2025)

Alignment Healthcare's Shares Outstanding history spans 6 years, with the latest figure at $204.2 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 6.45% year-over-year to $204.2 million; the TTM value through Dec 2025 reached $204.2 million, up 6.45%, while the annual FY2025 figure was $204.2 million, 6.45% up from the prior year.
  • Shares Outstanding reached $204.2 million in Q4 2025 per ALHC's latest filing, up from $200.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $204.2 million in Q4 2025 to a low of $187.2 million in Q4 2021.
  • Average Shares Outstanding over 5 years is $190.9 million, with a median of $188.7 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: rose 14.15% in 2021, then dropped 0.0% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $187.2 million in 2021, then rose by 0.05% to $187.3 million in 2022, then grew by 0.89% to $189.0 million in 2023, then rose by 1.5% to $191.8 million in 2024, then grew by 6.45% to $204.2 million in 2025.
  • Per Business Quant, the three most recent readings for ALHC's Shares Outstanding are $204.2 million (Q4 2025), $200.0 million (Q3 2025), and $198.0 million (Q2 2025).